Immunome, Inc.
IMNM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $273 | $144 | $258 | $143 |
| Short-Term Investments | $0 | $124 | $60 | $74 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $9 | $6 | $4 |
| Total Curr. Assets | $280 | $277 | $323 | $221 |
| Property Plant & Equip (Net) | $15 | $14 | $15 | $14 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $5 | $4 | $5 |
| Total NC Assets | $19 | $19 | $20 | $19 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $299 | $296 | $343 | $240 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $9 | $14 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $4 | $7 |
| Other Curr. Liab. | $25 | $18 | $18 | $33 |
| Total Curr. Liab. | $31 | $23 | $31 | $54 |
| LT Debt | $4 | $4 | $5 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $4 | $5 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $4 | $5 | $5 |
| Total Liabilities | $35 | $27 | $36 | $59 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$658 | -$601 | -$557 | -$516 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $922 | $870 | $865 | $697 |
| Total Equity | $264 | $269 | $307 | $181 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $299 | $296 | $343 | $240 |
| Net Debt | -$269 | -$140 | -$253 | -$139 |